Skip to content

A Study on Shishukalyanaka Ghrita for Children with ADHD

Clinical Evaluation Of Shishukalyanaka Ghrita In Management Of Attention-Deficit Hyperactivity Disorder(ADHD) - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/07/113815
Enrollment
30
Registered
2026-07-09
Start date
Unknown
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F909- Attention-deficit hyperactivity disorder, unspecified type

Interventions

None listed

Sponsors

Rishikul Campus
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Age between 6 to 12 years, Patient diagnosed with ADHD, Patient fit for DSM-5 criteria, Patient or guardian willing to take the treatment.

Exclusion criteria

Exclusion criteria: Patient before 6 years and above 12 years of age, Patient with history of Seizures, Cerebral palsy or brain injury and Patient with diagnosed Psychiatric illness.

Design outcomes

Primary

MeasureTime frame
Clinical Evaluation Of Shishukalyanaka Ghrita In Management Of Attention Deficit Hyperactivity Disorder(ADHD) Subjectively All Signs and Symptoms Are Given With Grading Depending Upon Their SeverityTimepoint: 15 Days

Secondary

MeasureTime frame
Clinical Evaluation Of Shishukalyanaka Ghrita In Management Of Attention Deficit Hyperactivity Disorder(ADHD) Subjectively All Signs and Symptoms Are Given With Grading Depending Upon Their SeverityTimepoint: 15 Days

Countries

India

Contacts

Public ContactJyotsana Chauhan

Rishikul Campus,Haridwar

keerti.vrm@gmail.com9997777833

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Aug 10, 2026